CD24 and breast carcinoma: To identify whether flubendazole inhibits breast cancer stem-like cells, we performed flow cytometry analysis to analyze the proportion of CS-like cell subpopulation in breast cancer cells based on the expression of CD44 and CD24 (CD44high/CD24lowconfiguration).